Skip to content
  • To US Financial Professionals servicing non-US persons     Change
  • Contact us
    • Subscriptions
      • Select Preferences
      • Log in
search bar
Janus Henderson Investors
  • Who we are
        • About us

        • Our people

        • Environmental, Social and Governance (ESG)

        • Diversity, Equity and Inclusion (DEI)

        • Who we are
        • Our history
        • We provide access to some of the industry’s most talented and innovative thinkers.

          Meet our teams
        • Find out how environmental, social, and governance considerations are embedded within our organization and investment principles.

          Learn more
        • See how diversity, equity, and inclusion are valued and supported at Janus Henderson.

          Learn more
        • Who we are
        • Our history
        • Our people
        • Diversity, Equity and Inclusion
        • ESG Overview
  • Products
        • Filter by asset class

        • Equities
        • Fixed Income
        • Multi-Asset
        • Alternatives
        • View all products
        • View

        • Prices and performance
        • What we offer
        • Sustainable Solutions
        • Regulatory information

        • MiFID II / PRIIP
        • Notices
        • Fund charges
  • Insights
        • Explore insights

        • Analysis & studies
        • Features & outlooks
        • Timely & topical
        • Webcasts
        • View all insights
        • Market GPS

          2023 Investment Outlook:
          Finding the silver lining

          Explore
          GPS Map
        • Analysis & studies
        • Features & outlooks
        • Timely & topical
        • Webcasts
        • View all insights
  • Documents
{{banner.link_text}}
To US Financial Professionals servicing non-US persons

Vish Sridharan, MD

Research Analyst

Vish Sridharan is a Research Analyst on the Health Care Sector Research Team at Janus Henderson Investors, a position he has held since 2022. In this role, he is focused on biotechnology companies. Before joining the firm, he completed an internship at Farallon Capital Management on the healthcare team investing in public and private biotechnology companies. He completed a residency in internal medicine at Massachusetts General Hospital while also serving as a consultant for Slate Path Capital, where he advised on science intensive opportunities. Additionally, Vish has worked with numerous biotechnology, capital management and pharmaceutical firms while earning multiple professional degrees and performing research at the Dana Farber Cancer Center and Brigham and Women’s Hospital.

Vish received a bachelor of science degree (Hons) in chemistry from University of North Carolina, graduating Phi Beta Kappa and an MBA from Harvard Business School. He also earned a doctor of medicine degree from the Harvard-MIT Program in Health Science and Technology, graduating with honours. He has 3 years of financial industry experience.

Articles Written

Global Perspectives: Why biotech could be embarking on a new decade of growth
Mar 20, 2023
Features & Outlooks

Global Perspectives: Why biotech could be embarking on a new decade of growth

A wave of innovative therapies is beginning to hit the market, transforming the prospects of the biotech firms behind the science.

24 min read

  • United States
  • Financial Professionals
  • Individual Investor
  • Institutional
  • US Offshore
  • Investor relations
  • Careers
Marketing Communication. The information on this site is intended only for US Financial Professionals servicing non-US Persons.
 
Unless otherwise stated all data is sourced from Janus Henderson Investors.
  
Please note that not all of the funds, products or services described on this website are available in all jurisdictions. In particular, only the US sections of this website are available to US Persons and only the Latin America sections of this website are available to residents of Latin America. The other investment products described elsewhere on this site are not available to US or Latin America residents.
  
Issued by Janus Henderson Investors. Janus Henderson Investors is the name under which investment products and services are provided by Janus Henderson Investors International Limited (reg no. 3594615), Janus Henderson Investors UK Limited (reg. no. 906355), Janus Henderson Fund Management UK Limited (reg. no. 2678531), Henderson Equity Partners Limited (reg. no.2606646), (each registered in England and Wales at 201 Bishopsgate, London EC2M 3AE and regulated by the Financial Conduct Authority) and Janus Henderson Investors Europe S.A. (reg no. B22848 at 2 Rue de Bitbourg, L-1273, Luxembourg and regulated by the Commission de Surveillance du Secteur Financier).
  
We may record telephone calls for our mutual protection, to improve customer service and for regulatory record keeping purposes.
 
Janus Henderson, Knowledge Shared and Knowledge Labs are trademarks of Janus Henderson Group plc or one of its subsidiaries. © Janus Henderson Group plc.

Close Notification
TOP
You are now leaving janushenderson.com

You are now leaving our site and entering a website not operated by or affiliated with Janus Henderson Investors. While we aim to point you to useful external websites, we cannot be responsible for their content, opinions, advice or accuracy, even if you utilise the services on the linked site to invest in our products.

The protection of your personal information on other websites is not governed by Janus Henderson Investors privacy policy and Janus Henderson Investors cannot be responsible for the privacy policies utilised on such third party sites, nor for the implementation of such policies by those third parties.

You should review the Terms and Conditions of third party websites and contact the operators of such sites if you have any queries.

You are now leaving Janus Henderson's website and will be redirected to the website of the Securities and Exchange Commission (the "SEC"). Money market funds are required to provide the SEC with a monthly electronic filing of more detailed portfolio holdings information on Form N-MFP.

Janus Henderson is not responsible for the content, accuracy or timeliness and does not make any warranties, express or implied, with regard to the information obtained from other websites. This link should not be construed as either a recommendation or offer to by or sell any securities.

Region

Country

Language

What type of investor are you?